BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

India cleared the 4th vaccine for emergency use in the country, the US-made Moderna.

Mumbai-based pharma major Cipla has been allowed to import Moderna's Covid vaccine for restricted emergency use in India, where the vaccines used so far we...

June 30, 2021 | News

mRNA Vaccine Technology Holds Promise, but Faces Challenges

Numerous studies and statistics from national governments also suggest the data looks good regarding how the mRNA vaccines perform against emerging variant...

June 24, 2021 | Opinion

Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan

Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...

June 23, 2021 | News

eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®

eTheRNA immunotherapies NV a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announ...

June 23, 2021 | News

Manufacturing Strategies for mRNA Vaccines and Therapeutics

In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...

June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

June 15, 2021 | News

G7 Summit announces pledges of 870 million COVID-19 vaccine doses

COVAX welcomes dose sharing commitments for 870 million additional doses to support equitable access to vaccines in 2021 and 2022, with the aim to delive...

June 14, 2021 | News

EHA:Efficacy of Pfizer/BioNTech BNT162b2 vaccine in patients receiving CAR-T

The Pfizer/BioNTech BNT162b2 vaccine has been approved for the prevention of coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2) and is recommende...

June 14, 2021 | News

Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...

June 12, 2021 | News

FDA Takes Steps to Increase Availability of COVID-19 Vaccine

The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...

June 12, 2021 | News

Hummingbird Bioscience and Novogene to expand precision medicine testing

Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience's lead program, HMBD-001 Hummingbird Bioscience,...

June 09, 2021 | News

LivFul and Global Access Diagnostics announce partnership for COVID-19 test kit distribution

While new innovations are being developed, millions still lack access to simple, timely, quality testing to help curb the spread of disease. This partnersh...

June 09, 2021 | News

Ascletis Received China IND Approval for Chronic hepatitis B

Ascletis Pharma Inc. (HKEX: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND...

June 07, 2021 | News

Stay Connected